Ultrasound diagnosis, management and prognosis in a consecutive series of 27 cases of fetal hydrops following maternal parvovirus B19 infection

Fetal Diagnosis and Therapy

Volumn 30, Issue 1, 2011, Pages 41-47

  Chauvet, Agathe ^a   Dewilde, Anny ^a   Thomas, Dominique ^a   Joriot, Sylvie ^a   Vaast, Pascal ^a   Houfflin Debarge, Véronique ^a   Subtil, Damien ^a  

^a UNIV LILLE   (France)

Author keywords

Fetal anemia; Fetal hydrops; Long term prognosis; Parvovirus B19; Transfusion in utero

Indexed keywords

ANEMIA; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; ERYTHEMA INFECTIOSUM; EXCHANGE BLOOD TRANSFUSION; FETUS; FETUS ECHOGRAPHY; FETUS HYDROPS; HUMAN; HUMAN PARVOVIRUS B19; INTRAUTERINE BLOOD TRANSFUSION; MATERNAL DISEASE; MIDDLE CEREBRAL ARTERY; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SURVIVAL RATE;

EID: 85027926445     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000323821     Document Type: Article

References (29)

1. Brown T, Anand A, Ritchie LD, et al: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2: 1033-1034. (Pubitemid 14021728)
2. Harger JH, Adler SP, Koch WC, Harger GF: Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms. Obstet Gynecol 1998; 91: 413-420. (Pubitemid 28119845)
3. Rodis JF, Rodner C, Hansen AA, et al: Longterm outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998; 91: 125-128. (Pubitemid 28042347)
4. Rodis JF, Quinn DL, Gary GW Jr, et al: Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study. Am J Obstet Gynecol 1990;163: 1168-1171. (Pubitemid 20377392)
5. Sheikh AU, Ernest JM, O'Shea M: Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992; 167: 337-341.
6. Peters MT, Nicolaides KH: Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol 1990; 75: 501-504. (Pubitemid 20062311)
7. Morey AL, Morey AL, Nicolini U, et al: Parvovirus B19 infection and transient fetal hydrops. Lancet 1991; 337: 496.
8. Bellini C, Hennekam RC, Fulcheri E, et al: Etiology of nonimmune hydrops fetalis: A systematic review. Am J Med Genet A 2009; 149A:844-851.
9. Miller E, Fairley CK, Cohen BJ, Seng C: Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174-178. (Pubitemid 28096296)
10. Nagel HT, de Haan TR, et al: Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007; 109: 42-47. (Pubitemid 46035508)
11. Carbonne B, Nguyen A, Cynober E, et al: Prenatal diagnosis of anoxic cerebral lesions caused by profound fetal anemia secondary to maternal red blood cell alloimmunization. Obstet Gynecol 2008; 112: 442-444.
12. Levy R, Weissman A, Blomberg G, Hagay ZJ: Infection by parvovirus B19 during pregnancy: A review. Obstet Gynecol Surv 1997; 52: 254-259. (Pubitemid 27161320)
13. Fairley CK, Smoleniec JS, Caul OE, Miller E: Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346: 1335-1337.
14. Von Kaisenberg CS, Jonat W: Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 2001; 18: 280-288. (Pubitemid 32830505)
15. Pattison JR, Jones SE, Hodgson J, et al: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981; 1: 664-665.
16. Cosmi E, Mari G, Delle Chiaie L, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002; 187: 1290-1293. (Pubitemid 35397477)
17. Schwarz TF, Roggendorf M, et al: Human parvovirus B19 infection in pregnancy. Lancet 1988; 2: 566-567.
18. Naides SJ, Weiner CP: Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989; 9: 105-114. (Pubitemid 19072549)
19. Markenson GR, Yancey MK: Parvovirus B19 infections in pregnancy. Semin Perinatol 1998; 22: 309-317. (Pubitemid 28397552)
20. Essary LR, Vnencak-Jones CL, Manning SS, et al: Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods. Hum Pathol 1998; 29: 696-701. (Pubitemid 28322054)
21. Jordan JA, DeLoia DJ: Globoside expression within the human placenta. Placenta 1999; 20: 103-108. (Pubitemid 29039257)
22. Morey AL, Nicolini U, Welch CR, et al: Parvovirus B19 infection and transient fetal hydrops. Lancet 1991; 337: 496.
23. Von Kaisenberg CS, Bender G, Scheewe J, et al: A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 2001; 16: 427-432. (Pubitemid 33033387)
24. Mari G: Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: The untold story. Ultrasound Obstet Gynecol 2005; 25: 323-330. (Pubitemid 40547171)
25. Mari G, Zimmermann R, Moise KJ Jr, Deter RL: Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after two previous intrauterine transfusions. Am J Obstet Gynecol 2005; 193: 1117-1120. (Pubitemid 41285504)
26. Mari G, Deter RL, Carpenter RL, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342: 9-14. (Pubitemid 30020654)
27. Saltzman DH, Frigoletto FD, Harlow BL, et al: Sonographic evaluation of hydrops fetalis. Obstet Gynecol 1989; 74: 106-111. (Pubitemid 19168008)
28. Saint-Martin J, Choulot JJ, Bonnaud E, Morinet F: Myocarditis caused by parvovirus. J Pediatr 1990; 116: 1007-1008.
29. Yoto Y, Kudoh T, Asanuma H, et al: Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet 1994; 344: 624-625. (Pubitemid 24267245)